Cargando…

Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute–Designated Community Oncology Research Programs

PURPOSE: Clinical trial participation leads to progress in cancer care. Principal investigators (PIs) and clinical research associates (CRAs) play key roles in the provision and maintenance of clinical trial portfolios at their sites. Previous studies have evaluated the educational and resource need...

Descripción completa

Detalles Bibliográficos
Autores principales: Dickens, David S., Roth, Michael E., Pollock, Brad H., Langevin, Anne-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564137/
https://www.ncbi.nlm.nih.gov/pubmed/32396490
http://dx.doi.org/10.1200/JOP.19.00707
_version_ 1783595643763163136
author Dickens, David S.
Roth, Michael E.
Pollock, Brad H.
Langevin, Anne-Marie
author_facet Dickens, David S.
Roth, Michael E.
Pollock, Brad H.
Langevin, Anne-Marie
author_sort Dickens, David S.
collection PubMed
description PURPOSE: Clinical trial participation leads to progress in cancer care. Principal investigators (PIs) and clinical research associates (CRAs) play key roles in the provision and maintenance of clinical trial portfolios at their sites. Previous studies have evaluated the educational and resource needs of adult oncology providers, but nothing to date has focused on providers of pediatric oncology care. We aimed to identify the educational needs and clinical trial participation barriers at National Cancer Institute Community Oncology Research Program (NCORP) Children’s Oncology Group (COG) sites to improve the quality of site investigator engagement. METHODS: Quality improvement surveys of pediatric clinical research staff at NCORP sites were performed. The first was a web-based inquiry of NCORP COG PIs and lead CRAs to assess their general understanding of NCORP organizational structure and needs. The second survey of COG PIs was conducted by one-on-one telephone interviews aimed at identifying specific barriers to physician engagement and patient enrollment in clinical trial research. RESULTS: The majority of NCORP COG PIs and CRAs (63%) reported an incomplete understanding of NCORP structure, with approximately half expressing interest in developing stronger collaborations and engagement. Most NCORP COG PIs reported at least one shared barrier to clinical trial enrollment (78%), with inadequate protected time and research support (39% each) being the most frequently cited barriers. CONCLUSIONS: Contributions to pediatric cancer clinical research at COG NCORP sites could be enhanced through improved education, resources, and time allocation.
format Online
Article
Text
id pubmed-7564137
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-75641372020-10-22 Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute–Designated Community Oncology Research Programs Dickens, David S. Roth, Michael E. Pollock, Brad H. Langevin, Anne-Marie JCO Oncol Pract ORIGINAL CONTRIBUTIONS PURPOSE: Clinical trial participation leads to progress in cancer care. Principal investigators (PIs) and clinical research associates (CRAs) play key roles in the provision and maintenance of clinical trial portfolios at their sites. Previous studies have evaluated the educational and resource needs of adult oncology providers, but nothing to date has focused on providers of pediatric oncology care. We aimed to identify the educational needs and clinical trial participation barriers at National Cancer Institute Community Oncology Research Program (NCORP) Children’s Oncology Group (COG) sites to improve the quality of site investigator engagement. METHODS: Quality improvement surveys of pediatric clinical research staff at NCORP sites were performed. The first was a web-based inquiry of NCORP COG PIs and lead CRAs to assess their general understanding of NCORP organizational structure and needs. The second survey of COG PIs was conducted by one-on-one telephone interviews aimed at identifying specific barriers to physician engagement and patient enrollment in clinical trial research. RESULTS: The majority of NCORP COG PIs and CRAs (63%) reported an incomplete understanding of NCORP structure, with approximately half expressing interest in developing stronger collaborations and engagement. Most NCORP COG PIs reported at least one shared barrier to clinical trial enrollment (78%), with inadequate protected time and research support (39% each) being the most frequently cited barriers. CONCLUSIONS: Contributions to pediatric cancer clinical research at COG NCORP sites could be enhanced through improved education, resources, and time allocation. American Society of Clinical Oncology 2020-10 2020-05-12 /pmc/articles/PMC7564137/ /pubmed/32396490 http://dx.doi.org/10.1200/JOP.19.00707 Text en © 2020 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/)
spellingShingle ORIGINAL CONTRIBUTIONS
Dickens, David S.
Roth, Michael E.
Pollock, Brad H.
Langevin, Anne-Marie
Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute–Designated Community Oncology Research Programs
title Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute–Designated Community Oncology Research Programs
title_full Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute–Designated Community Oncology Research Programs
title_fullStr Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute–Designated Community Oncology Research Programs
title_full_unstemmed Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute–Designated Community Oncology Research Programs
title_short Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute–Designated Community Oncology Research Programs
title_sort understanding the barriers to pediatric oncologist engagement and accrual to clinical trials in national cancer institute–designated community oncology research programs
topic ORIGINAL CONTRIBUTIONS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564137/
https://www.ncbi.nlm.nih.gov/pubmed/32396490
http://dx.doi.org/10.1200/JOP.19.00707
work_keys_str_mv AT dickensdavids understandingthebarrierstopediatriconcologistengagementandaccrualtoclinicaltrialsinnationalcancerinstitutedesignatedcommunityoncologyresearchprograms
AT rothmichaele understandingthebarrierstopediatriconcologistengagementandaccrualtoclinicaltrialsinnationalcancerinstitutedesignatedcommunityoncologyresearchprograms
AT pollockbradh understandingthebarrierstopediatriconcologistengagementandaccrualtoclinicaltrialsinnationalcancerinstitutedesignatedcommunityoncologyresearchprograms
AT langevinannemarie understandingthebarrierstopediatriconcologistengagementandaccrualtoclinicaltrialsinnationalcancerinstitutedesignatedcommunityoncologyresearchprograms